Early Stage Recruitment Strategies for Complex Trials & Special Populations: How to Deliver Full Panels On-Time

Clinical Trials, Life Sciences, Pharmaceutical,
  • Thursday, November 21, 2013

Recruiting full panels on-time is crucial to efficiently progressing through clinical development. With the increasing need for adaptive/complex clinical trials and the use of special populations earlier in development, clinical research providers are focusing on implementing more effective recruitment strategies.

This webinar will highlight a solutions-based approach to filling large panels for complex trials, while incorporating special populations in a high volume environment. We will elaborate on how we have used our database optimization as well as study-specific recruitment strategies to ensure panels are filled quickly and efficiently, while maintaining a 98% recruitment performance.

Specifically using three case studies focusing on special populations (Hypogonadal males, Type I/II Diabetes and Post-Menopausal women), we will demonstrate how optimal recruitment strategies can be effectively used to meet increasingly complex participant requirements in early stage clinical development.


Ingrid Holmes, Senior Director, Clinical Operations, Algorithme Pharma

Ingrid joined LAB Pharmacological Research in 1995, and worked in roles with increasing responsibility within the clinical, quality control and data management departments. After LAB was acquired by MDS Pharma Services in 1999, she held various management roles in Early Stage Clinical Operations in Montreal, a site with approximately 300 Phase I beds. She progressed to Director of Business Operations and Continuous Improvement in 2009, overseeing the financial and quality performance of five international clinical sites. Here she successfully implemented company-wide management systems, including financial, client service and operational Key Performance Indicators (KPI). In her varying roles in Clinical Research, she has gained extensive experience in conducting Early Stage Trials, International Regulatory Requirements, Business Operations, Quality Management Systems and Lean Six Sigma. In 2011, Ingird joined Algorithme Pharma where she currently has the role of Senior Director, Clinical Operations.

Message Presenter

Petra Hillebrand, Vice President, Integrated Services, Altasciences

In 2010, Petra joined Algorithme Pharma as Director of Process Improvement and subsequently took responsibility for the Screening and Recruiting team. She has led the implementation of a Lean Six Sigma program at Algorithme Pharma including the training of 18 Green Belts and oversees the execution of all LSS projects. Her software deployment experience continues to be applied with the redesign and implementation of new recruiting software to optimize the participant recruiting process. As a part of the Senior Management Committee, Petra is also responsible for managing the capital budget and the Facilities Management group.

With the acquisition of Vince and Associates in 2012, Petra assumed the role of Vice President of Integrated Services for Altasciences and is responsible for all cross company shared services, capital budget management, recruiting and screening processes and new software implementation.

Message Presenter

Who Should Attend?

VPs, Directors, Heads, Clinic Managers, Scientists, Recruitment Managers, Study Coordinators, Study Monitors, Clinic Research Associates involved in:

  • R&D Clinical Operations (Pharmacology, Toxicology, Clinical Safety, Clinical Research, Principal Research, Research Investigation, Drug Development)
  • Outsourcing Clinical Site Management
  • Regulatory Affairs
  • Outsourcing Management

Xtalks Partner

Algorithme Pharma

Founded in 1992, Algorithme Pharma is an established early stage clinical contract research organization (CRO) providing multiple research services for Pharmaceutical, biotechnology and generic drug industries. Algorithme Pharma’s facilities include a 6-unit clinic with 224 beds and a 20,000 square foot Bioanalytical laboratory.

With over 20 years’ experience in clinical research, Algorithme Pharma successfully completes over 200 clinical trials annually in Phase I/IIa and Bioequivalence. Combined with Algorithme Pharma’s active participant list of over 40,000 healthy participants, recruitment levels and timelines far exceed industry standards and ensure on-time study starts. In addition, our network of specialized clinicians and relationships with local hospitals provides access to a wide range of patient populations.

Furthermore, Algorithme Pharma performs large and small molecule bioanalysis on samples from Preclinical to Phase IV studies. The organization is comprised of almost 500 professionals from the medical and scientific fields who work together to provide quality input into study design, conduct and reporting in a wide range of therapeutic areas.

Media Partner

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account